Mc Kinley Carter Wealth Services, Inc. Moderna, Inc. Transaction History

Mc Kinley Carter Wealth Services, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$117.13 - $176.59 $145,241 - $218,971	-1,240 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$221.9 - $484.47 $166,425 - $363,352	-750 Reduced 37.69%	1,240 $477,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $130,822 - $338,021	1,990 New	1,990 $208,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mc Kinley Carter Wealth Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Kinley Carter Wealth Services, Inc. with notifications on news.